Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Impact of Stigma on People with Opioid Use Disorder, Opioid Treatment, and Policy
Ali Cheetham, Louisa Picco, Anthony Barnett, et al.
Substance Abuse and Rehabilitation (2022) Vol. Volume 13, pp. 1-12
Open Access | Times Cited: 123

Showing 26-50 of 123 citing articles:

Mapping the Lived Experience of Substance Use Stigma: A Conceptual Framework of Salient Attitudes, Beliefs, and Behaviors in Rural-Dwelling People Who Use Drugs
Adams L Sibley, Sophia M. Bartels, Seth M. Noar, et al.
Social Science & Medicine (2025) Vol. 372, pp. 117967-117967
Closed Access
Journey mapping drug seizures among police, public health and local nonprofit professionals, and community members who use drugs
Bethany Hedden-Clayton, Erin Comartin, Jennifer Carroll, et al.
International Journal of Drug Policy (2025) Vol. 139, pp. 104774-104774
Closed Access
“Patients, Trauma Survivors, Sweethearts, or Troublemakers?”: A Discourse Analysis of General Practitioners’ and Pharmacists’ Accounts of Clients on Opioid Substitution Treatment
L. Bonte, Liesbet Goubert, Melissa Ceuterick
Qualitative Health Research (2025)
Closed Access
Experiences of stigmatization among people who use drugs in the initial year of British Columbia's drug decriminalization policy: A qualitative study
Farihah Ali, Cayley Russell, Savannah Torres-Salbach, et al.
International Journal of Drug Policy (2025) Vol. 139, pp. 104791-104791
Open Access
Prescribing poetry: a multi-level intervention against loneliness
Elisabeth A. T. Evers, Ashley Thuthao Keng Dam
Journal of Poetry Therapy (2025), pp. 1-24
Open Access
“Either way, they will use. And so, probably, would you:” A critical discourse analysis of harm reduction portrayal in United States opinion news media
Hannah A. Carlon, Hanna M. Hebden, Nina C. Christie, et al.
International Journal of Drug Policy (2025) Vol. 140, pp. 104801-104801
Closed Access
Pain Management in Cancer Patients With Artificial Intelligence: Narrative Review
Golnar Ghane, Raoofeh Karimi, Amir Mohammad Chekeni, et al.
Scientifica (2025) Vol. 2025, Iss. 1
Open Access
Experiences of healthcare discrimination and treatment outcomes among pregnant and postpartum people with opioid use disorder
Joyce H. Xu, Emily DeFranco, Aaron Murnan, et al.
Journal of Substance Use and Addiction Treatment (2025) Vol. 174, pp. 209707-209707
Closed Access
Exploring the need for overdose prevention centers in England: A qualitative community-based participatory study on the perspectives of people who use drugs in public and semi-public environments
Benjamin D. Scher, Mat Southwell, Magdalena Harris, et al.
International Journal of Drug Policy (2025) Vol. 140, pp. 104816-104816
Open Access
“I don’t tell anyone I have them:” Experiences with opioid stigma from the perspective of survivors living with chronic cancer-related pain and clinicians that care for them
Sarah Bell, Megan Hamm, Julia Wasilewski, et al.
Journal of Pain (2025), pp. 105411-105411
Closed Access
Buprenorphine misinformation and willingness to treat patients with opioid use disorder among primary care-aligned health care professionals
Berkeley Franz, Lindsay Y. Dhanani, O. Hall, et al.
Addiction Science & Clinical Practice (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 3
Assessing experts’ perspectives on challenges in substance misuse prevention, harm reduction, and treatment to shape funding priorities in New York State
Daniel J. Kruger, Hilary M. Kirk, Kenneth E. Leonard, et al.
Harm Reduction Journal (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 3
Strategies to Improve Access to Care for Patients With Opioid Use Disorder
Ligang Liu, Chen Zhang, Andrea E. Bonny, et al.
Annals of Pharmacotherapy (2024)
Closed Access | Times Cited: 3
Patient-Provider Shared Decision-Making, Trust, and Opioid Misuse Among US Veterans Prescribed Long-Term Opioid Therapy for Chronic Pain
Vanessa C. Somohano, Crystal Lederhos Smith, Somnath Saha, et al.
Journal of General Internal Medicine (2023) Vol. 38, Iss. 12, pp. 2755-2760
Closed Access | Times Cited: 7
First-hand accounts of structural stigma toward people who use opioids on Reddit
Evan L. Eschliman, Karen Choe, Alexandra DeLucia, et al.
Social Science & Medicine (2024) Vol. 347, pp. 116772-116772
Closed Access | Times Cited: 2
Integrating Nursing Practice and Policy in Opioid Overdose Prevention: Analysis of the Opioid‐Overdose Reduction Continuum of Care Approach Practice Guide
Evans F. Kyei, Rockson Ansong, Grace K. Kyei
Journal of Advanced Nursing (2024)
Open Access | Times Cited: 2
Influencers and ‘brain building’ smart drugs: A content analysis of services and market activities of nootropic influencers over social media
Luke Cox, Timothy Piatkowski
Performance Enhancement & Health (2024), pp. 100289-100289
Closed Access | Times Cited: 2
The intersection of substance use stigma and anti-Black racial stigma: A scoping review
Rashmi Ghonasgi, Maria Paschke, Rachel P. Winograd, et al.
International Journal of Drug Policy (2024) Vol. 133, pp. 104612-104612
Open Access | Times Cited: 2
Opioid Regulation of Social Homeostasis: Connecting Loneliness to Addiction
Guro Engvig Løseth, Marie Eikemo, Siri Leknes
Biological Psychiatry (2024)
Open Access | Times Cited: 2
Need for opioid agonist therapy among opioid users of open drug scenes
Heike Zurhold, Silke Kühn, Jens Reimer, et al.
Heroin addiction and related clinical problems (2024) Vol. 26, pp. 1-10
Closed Access | Times Cited: 2
Assessing challenges and solutions in substance abuse prevention, harm reduction, and treatment services in New York State
Daniel J. Kruger, Hilary M. Kirk, Kenneth E. Leonard, et al.
SSM - Health Systems (2024), pp. 100039-100039
Open Access | Times Cited: 2
Application of the COM-B model to patient barriers and facilitators of retention in medication treatment for opioid use disorder in rural Northeastern United States: A qualitative study
Melissa N. Poulsen, Patrick B. Asdell, Wade H. Berrettini, et al.
SSM - Mental Health (2022) Vol. 2, pp. 100151-100151
Open Access | Times Cited: 10
Racial and Ethnic Differences in Emergency Department Wait Times for Patients with Substance Use Disorder
Samantha S. Goldfarb, Katelyn Y. Graves, Karen W. Geletko, et al.
Journal of Emergency Medicine (2023) Vol. 64, Iss. 4, pp. 481-487
Closed Access | Times Cited: 5
Promises and perils of the FDA's over-the-counter naloxone reclassification
David T. Zhu, Suzanne Tamang, Keith Humphreys
The Lancet Regional Health - Americas (2023) Vol. 23, pp. 100518-100518
Open Access | Times Cited: 5
Fentanyl Exposure and Detection Strategies Utilized by Clinical Trial Participants Seeking Linkage to Opioid Use Disorder Treatment at a Syringe Service Program
Dennis P. Watson, Bradley Ray, Peter Phalen, et al.
Journal of Medical Toxicology (2023) Vol. 20, Iss. 1, pp. 13-21
Open Access | Times Cited: 5

Scroll to top